Forte Biosciences Stock Market Value
| FBRX Stock | USD 15.52 0.12 0.77% |
| Symbol | Forte |
Forte Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Forte Biosciences. If investors know Forte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Forte Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.38) | Return On Assets (0.81) | Return On Equity (1.71) |
The market value of Forte Biosciences is measured differently than its book value, which is the value of Forte that is recorded on the company's balance sheet. Investors also form their own opinion of Forte Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Forte Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forte Biosciences' market value can be influenced by many factors that don't directly affect Forte Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forte Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Forte Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forte Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Forte Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Forte Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Forte Biosciences.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Forte Biosciences on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Forte Biosciences or generate 0.0% return on investment in Forte Biosciences over 30 days. Forte Biosciences is related to or competes with Lyra Therapeutics, Hookipa Pharma, SAB Biotherapeutics, Cadrenal Therapeutics,, Monopar Therapeutics, Spero Therapeutics, and Bolt Biotherapeutics. Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States More
Forte Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Forte Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Forte Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.17 | |||
| Information Ratio | 0.1 | |||
| Maximum Drawdown | 18.12 | |||
| Value At Risk | (6.33) | |||
| Potential Upside | 6.65 |
Forte Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Forte Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Forte Biosciences' standard deviation. In reality, there are many statistical measures that can use Forte Biosciences historical prices to predict the future Forte Biosciences' volatility.| Risk Adjusted Performance | 0.0909 | |||
| Jensen Alpha | 1.57 | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.3943 | |||
| Treynor Ratio | 1.0 |
Forte Biosciences Backtested Returns
Forte Biosciences is very risky given 3 months investment horizon. Forte Biosciences secures Sharpe Ratio (or Efficiency) of 0.11, which denotes the company had a 0.11% return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.78% are justified by taking the suggested risk. Use Forte Biosciences Downside Deviation of 4.17, coefficient of variation of 937.32, and Mean Deviation of 5.69 to evaluate company specific risk that cannot be diversified away. Forte Biosciences holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.74, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Forte Biosciences will likely underperform. Use Forte Biosciences potential upside, as well as the relationship between the accumulation distribution and price action indicator , to analyze future returns on Forte Biosciences.
Auto-correlation | 0.40 |
Average predictability
Forte Biosciences has average predictability. Overlapping area represents the amount of predictability between Forte Biosciences time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Forte Biosciences price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Forte Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 16.66 |
Forte Biosciences lagged returns against current returns
Autocorrelation, which is Forte Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Forte Biosciences' stock expected returns. We can calculate the autocorrelation of Forte Biosciences returns to help us make a trade decision. For example, suppose you find that Forte Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Forte Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Forte Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Forte Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Forte Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Forte Biosciences Lagged Returns
When evaluating Forte Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Forte Biosciences stock have on its future price. Forte Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Forte Biosciences autocorrelation shows the relationship between Forte Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Forte Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.